About Semglee (Insulin Glargine)
SEMGLEE (insulin glargine injection) is a sterile solution for subcutaneous use. Insulin glargine is a recombinant human long-acting insulin analog.
SEMGLEE (Insulin Glargine)
Indicated to improve glycemic control in adults and pediatric patients from 6 years old with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
- Limitations of use: SEMGLEE is not recommended for the treatment of diabetic ketoacidosis.
What is SEMGLEE?
- SEMGLEEÂ is a once-daily long-acting insulin analogue (100 units/ml).
- SEMGLEEÂ is available as a solution for injection in 10ml multiple dose vials or in 3ml single-patient-use
prefilled injector pens.
Semglee (Insulin Glargine) aids in the control of diabetes mellitus in cats. This medication works to regulate your diabetic cat’s blood sugar. When blood glucose levels are normal, your cat’s body will work efficiently and diabetes symptoms will be fewer.
Showing the single result
Showing the single result